Inmune Bio INMB
As noted in Item 5.07 below, on June 1, 2021
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001213900-21-030752
- Document
- 8-K
- Exhibit 10.1
- Inmune Bio, Inc. 2021 stock incentive plan
- Reports an executive or board change (5.02)
- Reports shareholder vote results (5.07)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Fitlife Brands FTLF public float $51M, Jun 30, 2025
- Immucell ICCC public float $51M, Jun 30, 2025
- Cue Biopharma CUE public float $52M, Jun 30, 2025
- Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
- Precision Biosciences DTIL public float $47M, Jun 30, 2025
